维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Weckermann D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Sentinel lymph node dissection for prostate cancer: experience with more than 1 000 patients显示文摘	Weckermann D Dorn R Trextz M	2007	J Urol2007，177，3：	1
	2	Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues显示文摘	Weckermann D Harzmann R	2004	Eur Urol2004，46，3：	1
	3	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA 显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephol1999，31，3：	1
	4	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
	5	Hormone therapy in prostate cancer:LHRH antagonists versus LHRH analogues显示文摘	Weckermann D Harzmann R	2004	Eur Urol2004，46，3：	1
	6	查看详情显示文摘	Weckermann D Muller P Wawroschek F		0，，：	1
	7	Perioperative activa- tion of disseminated tumor cells in bone marrow of patients with prostate cancer 显示文摘	Weckermann D Polzer B Ragg T	2009	J Clin Oncol2009，27，10：	1
	8	Improved discrimination of prostate cancer and benign prostatic hy- perplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
	9	Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of or : 10 ng/mL and biopsy Gleason score of or : 6, and their influence on PSA progression-free survival after radical prostateetomy 显示文摘	WECKERMANN D GOPPELT M DORN R	2006	BJU Int2006，97，6：	1
	10	Sentinellymph node dissection for prostate cancer:Experience with morethan 1000patients显示文摘	WECKERMANN D DORN R TREFZ M	2007	J Urol2007，177，：	1
	11	The sentinel lymph node concept in prostate cancer-first results of gamma probe-guided sentinel lymph node identification显示文摘	Wawroschek F Vogt H Weckermann D	1999	Eur Urol1999，36，6：	1
	12	Im- proved discrimination of prostate cancer and benign pros tatic hyperplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
	13	The sentinel lymph node concept in prostate cancer-first results of gamma probe-guided sentinel lymph node identification显示文摘	Wawroschek F Vogt H Weckermann D	1999	Eur Urol1999，36，6：	1
	14	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1
	15	A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer显示文摘	MECKLENBURG I WECKERMANN D ZIPPELIUS A	2007	J Immunol Methods2007，323，2：	1
	16	Improved discrim- ination of prostate cancer and benign prostatic hyperplasia by Means of the quotient of free and total PSA 显示文摘	Weckermann D Maassen C Wawrosehek F	1999	Int Urol Nephrol1999，31，：	1
	17	Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues显示文摘	WECKERMANN D HARZMANN R	2004	Eur Urol2004，46，3：	1
	18	Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA 显示文摘	Weckermann D Maassen C Wawroschek F	1999	Int Urol Nephrol1999，31，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费